NCT05694247View on ClinicalTrials.gov

Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 27, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2026

Conditions
Corneal DiseaseCorneal OpacityCorneal Injuries
Interventions
DEVICE

CorNeat KPro

The optical component of the CorNeat KPro will be implanted into a circular disc of the cornea (as performed in standard penetrating keratoplasty surgery) and the skirt component will be embedded under a 360º conjunctival flap.

Trial Locations (6)

34295

RECRUITING

CHU de Montpellier, Montpellier

4941492

RECRUITING

Rabin Medical Center - Beilinson, Petah Tikva

V5Z 3N9

RECRUITING

University of British Columbia, Vancouver

M5T 2S8

NOT_YET_RECRUITING

UHN - University Health Network, Toronto

Unknown

RECRUITING

Hopital Fondation Adolphe de Rothschild, Paris

1105 AZ

NOT_YET_RECRUITING

Amsterdam UMC - Location AMC, Amsterdam

All Listed Sponsors
lead

CorNeat Vision Ltd.

INDUSTRY